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Radioimmunoassays of giucagon in plasma may be complicated by interaction with other substances of high molecular mass. Precipitates of such substances with ammonium sulfate showed, after isoelectric focusing, two fractions having glucagon immunoreactivity. One fraction (p1-.'lO) evidently is associated with the Fc portion (but not the Fab portion) of purified polyclonal immunoglobulin G (lgG). Equal amounts of purified monoclonal lgG of various subclasses, especially lgG 1, gave different "glucagon" readings, suggesting that some lgG may interfere more strongly than others. The other fraction (p15-6) appeared less consistently, and on gel chromatography appeared to be slightly larger than lgG. Together these fractions add about 50-100 ng/L to the immunoreactive glucagon values in plasma. Therefore methods in which glucagon is extracted before assay should be used for determining the concentration of glucagon present physiologically. (3) . Neither the identity nor source of these high-Mr substances has yet been clarified.
According to the literature, "big plasma glucagon" appears to be associated with immunoglobulin G (IgG) in many ways (3), but no correlation between the concentrations of IgG and "big plasma glucagon" in plasma was found when "big plasma glucagon"
was measured with antiserum 30K (4). We have recently prepared a glucagon antiserum, E7, that recognizes the same immunoreactive components in plasma as does antiserum 30K (5, 6). However, antiserum E7 measured zero values for high-Mr substances in a patient with aganunaglobulinemia, and gave higher values for these high-Mr substances than does antiserum 30K (5). Therefore, we used antiserum E7 to reinvestigate the relation between these substances and IgG. Our study shows that preparations of the high-Mr substances from human plasma are heterogeneous on isoelectric focusing. The results suggest that IgG is one of the sources of the high-Mr substances.
The results demonstrate as well the presence in plasma of another fraction of high Mr. which needs further characterization. Their purity was checked by analytical methods (13) (14) (15) (16) and was always found to exceed 90% by these criteria. The subclass of the monoclonal IgGs was determined as described elsewhere (17, 18) . All preparations of polyclonal lgG and monoclonal immunoglobulins were dialyzed exhaustively against distilled water and lyophilized before being stored at room temperature.
Materials and Methods
Preparation
To exclude contamination of the immunoglobulins by glucagon, aliquots of the 20 g/L polyclonal IgG solution in assay buffer were subjected to gel filtration on Sephadex G-200.All isnmunoreactivity equivalent to glucagon was found in the IgG peak, none in the portion of the effluent in which glucagon appears. Pooled fractions (4 mL) from an isoelectric focusing experiment (near pH 5) on the high-M. substances were applied to a 1. (Figure 2 ). In four of six experiments, another IRG was localized in the pH range between 5 and 6 (or close to 5) (Figure 1 ). This showed that its main portion eluted slightly before the 1I-labeled IgG-marker (Figure 3) , suggesting a part of this fraction to be of somewhat greater molecular size. This IRG was not found in the control experiments in which the polyclonal IgG was subjected to isoelectric focusing.
In some cases we saw a third IRG, not exceeding 1 ng/L of the original plasma in the pH range 4-4.4, where the albumin was focused. 80 (20) 25 (6) 1000 (50) 300 (15) 45 (15) 13 (5) 400 (50) 115 ( 70 (15) 120 (20) 700 (60) 20 (5) 35 (6) 200 (20) 30 (10) 90 ( creasing amounts of differently purified polyclonal IgG showed that IgG interfered in proportion to its concentration in two glucagon assays. Thus, our study confirms previous reports that immunoglobulins interfere with the radioimmunoassay of glucagon (3, 4, 22, 23 and the concentration of polyclonal IgG when they examined patients with high concentrations of "big plasma glucagon."
The IRG with p1 between 5 and 6 and close to 5 is still unidentified.
By our method, this immunoreactivity was apparent in only four of six individuals, and it varied in concentration among these four individuals. We roughly estimate its Mr to be about 200 000.
In conclusion, our study shows that both IgG and some other poorly characterized high-Me component may substantially interfere in two glucagon assays. Their combined addition to the immunoreactive glucagon values is about 100 ng/L in the glucagon assay with antiserum E7 and about 50 ng/L in the assay with antiserum 30K. Methods involving extraction of glucagon and precipitation of the interfering high-Mr components before determining the physiological concentration of glucagon have been introduced for antisera 30K and E7 (24, 25) . The usefulness and practicality of this extraction have been validated with plasma samples from people subjected to various A-cell stimulation and suppression tests, and the accuracy of the results has been demonstrated in comparison with another carboxyl-terminal-directed antiserum (4305), which does not recognize the high-Mr components (25) .
